---
category: listing
circular_id: 270e1e7aa7ecdf28
date: '2026-01-19'
description: Biocon Ltd. has listed 112,664,585 new equity shares on BSE following
  a Qualified Institutional Placement at Rs. 368.35 per share, effective January 20,
  2026.
draft: false
guid: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={CBAF212E-B112-493C-8167-5B1F02F4406E}&noticeno=20260119-12&dt=01/19/2026&icount=12&totcount=40&flag=0
impact: medium
impact_ranking: medium
importance_ranking: medium
justification: Significant dilution event with 112.66 million shares adding to free
  float through QIP. Medium impact due to substantial share count increase though
  QIP pricing suggests institutional confidence.
pdf_url: https://www.bseindia.com/markets/MarketInfo/DownloadAttach.aspx?id=20260119-12&attachedId=
processing:
  attempts: 1
  content_hash: 3e9542a59fa0fc91
  processed_at: '2026-01-19T15:48:05.482795'
  processor_version: '2.0'
  stage: completed
  status: published
published_date: '2026-01-19T10:54:18+00:00'
rss_url: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={CBAF212E-B112-493C-8167-5B1F02F4406E}&noticeno=20260119-12&dt=01/19/2026&icount=12&totcount=40&flag=0
severity: low
source: bse
stocks:
- BIOCON
tags:
- listing
- equity-shares
- qip
- qualified-institutional-placement
- new-securities
- biocon
title: Listing of New Securities of Biocon Ltd. - QIP Allotment
---

## Summary

Biocon Ltd. (Scrip Code: 532523, ISIN: INE376G01013) has listed 112,664,585 new equity shares of Rs. 5 each on BSE following a Qualified Institutional Placement (QIP) to Qualified Institutional Buyers. The shares are admitted for trading with effect from January 20, 2026, and rank pari-passu with existing equity shares.

## Key Points

- 112,664,585 new equity shares of Rs. 5 each allotted to QIBs through QIP
- Issue price: Rs. 368.35 per share
- Allotment date: January 14, 2026
- Trading commencement date: January 20, 2026
- Distinguished numbers: 1508243189 to 1620907773
- New shares rank pari-passu with existing equity shares
- Total fundraise: Approximately Rs. 41,498 crore

## Regulatory Changes

No regulatory changes. This is a standard listing notification following SEBI QIP regulations.

## Compliance Requirements

- Trading members are informed of the new securities listing
- Members requiring clarification should contact Karan Shah (Tel: 9833307464)
- Standard trading and settlement procedures apply to the new shares

## Important Dates

- **January 14, 2026**: Date of allotment
- **January 19, 2026**: Notice date
- **January 20, 2026**: Trading commencement date (Tuesday)

## Impact Assessment

**Market Impact**: The QIP adds approximately 112.66 million shares to Biocon's outstanding equity, representing a significant dilution event. The issue price of Rs. 368.35 reflects institutional investor appetite and confidence in the company.

**Operational Impact**: Minimal operational impact on trading members. The new shares will trade alongside existing shares with identical rights and privileges (pari-passu status).

**Liquidity Impact**: Medium positive impact expected as the substantial share count increase will enhance free float and potentially improve liquidity in Biocon stock.